✦ LIBER ✦
Response of ovarian carcinomas to gefitinib–carboplatin–paclitaxel combination is not associated with EGFR kinase domain somatic mutations
✍ Scribed by Ludovic Lacroix; Patricia Pautier; Pierre Duvillard; Nelly Motté; Patrick Saulnier; Jean-Michel Bidart; Jean-Charles Soria
- Book ID
- 102275559
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- French
- Weight
- 51 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Recent reports suggest that mutations in the epidermal growth factor receptor (EGFR) predict sensitivity to EGFR kinase inhibitors. 1,2 Patients with lung cancer (70-100%) har